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The Ending Eclampsia Project conducted a baseline landscape analysis in 2015 followed by interventions 
to scale up underutilized interventions and commodities to improve access to early detection and treatment 
of preeclampsia and eclampsia. This report presents a repeat landscape analysis describing changes in 
prevention, detection, management and referral of pre-eclampsia and eclampsia. We are grateful for all 
those who provided programmatic and facility-based support to the scale up activities, including the Federal 
and state ministries of Health in Cross River, Ebonyi, and Kogi states and the USAID Mission Office in 
Nigeria.  
We acknowledge professional associations, implementing partners, and individual USAID colleagues 
(Joseph Monehin, Alaa El-Bashir, Emily Hillman, and Deborah Armbruster) who provided valuable inputs 
during project implementation and dissemination. The successful completion of the study would not have 
been possible without the dedication of service providers in the participating health facilities. We thank all 
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Executive Summary  
In the last three decades, global maternal mortality has decreased by almost 45 percent. Despite this 
overall improvement, approximately 830 women still die every day from largely preventable pregnancy 
complications, and sub-Saharan Africa alone accounts for over 66 percent of global maternal deaths. The 
majority of Nigeria’s more than 58,000 maternal deaths in 2015 were caused by pre-eclampsia, eclampsia, 
or postpartum hemorrhage. Pre-eclampsia and eclampsia are now the leading direct causes of maternal 
mortality in Nigeria and, with postpartum hemorrhage, account for more than one third of severe maternal 
outcomes (23.4% and 14.4%, respectively). 
In response, in 2015 the Ending Eclampsia project analyzed the country’s six geo-political zones’ (covering 
seven states) primary and secondary health care facilities’ preparedness for response to the needs of 
pregnant women with pre-eclampsia and eclampsia. The project then introduced a primary health care 
model to enhance both the capacities and service quality of 180 facilities to address pre-eclampsia and 
eclampsia in three of the seven states surveyed—Cross River, Ebonyi, and Kogi. This report describes the 
post-intervention evaluation.  
Primary and secondary health care providers’ knowledge and practice improved: Notably, community health 
extension workers who provide primary care, if trained and mentored, can effectively detect pre-eclampsia 
early, and manage it with a loading dose of magnesium sulphate (when indicated) preceding referrals. In 
addition, all stakeholders involved in the evaluation support full implementation of the national revised 
task shifting policy permitting primary care providers (community health extension workers and health 
officers) to detect and provide loading doses of magnesium sulphate to women with severe pre-eclampsia 
and eclampsia. Primary and secondary health care providers have shown promise in their ability to diagnose 
and classified sub-sets of hypertensive disorders in pregnancy. This is important because specific care 
pathway for each sub-type varies.  
Training logistics officers specifically on commodity logistics and supplies resulted in fewer stock outs at 
facilities. More efforts are required, however, for sustaining policy-maker advocacy for improved human 
resources management in addition to a regular and responsive maternal health commodity management 
system. International and local guidelines for managing hypertensive disorders in pregnancy are not 
generally available sub-nationally, and where available, providers are not trained to use them properly, 
resulting in missed opportunities for arresting hypertensive development. Future efforts should focus on 
eliminating these gaps. 
This evaluation’s results also show that empowered pregnant women request quality maternal health 
services (during antenatal visits) and ask questions about their health and those of their unborn infants. 
Trained personnel with essential commodities and tools will not result in significant progress if pregnant 
women do not register themselves early in the first trimester for antenatal care, when pre-eclampsia is 





In the last three decades, global maternal mortality has decreased by almost 45 percent, but approximately 
830 women still die daily from largely preventable pregnancy complications (World Health Organization 
2018, World Health Organization, UNICEF, UNFPA, World Bank Group, United Nations Population Division 
2015). Despite this overall improvement, low- and middle income countries continue to bear 99 percent of 
the burden of maternal deaths, with sub-Saharan Africa alone accounting for over 66 percent of global 
maternal deaths (World Health Organization et al. 2015). The majority of Nigeria’s more than 58,000 
maternal deaths in 2015 were caused by pre-eclampsia and eclampsia (PE/E) and postpartum hemorrhage 
(PPH) (Oladapo et al. 2015, World Health Organization et al. 2015). PE/E is now the leading direct cause 
of maternal mortality in Nigeria and, with PPH, accounts for more than one third of severe maternal 
outcomes (23.4% and 14.4%, respectively, Oladapo et al. 2015).  
Since 2015, the Ending Eclampsia project, with support from USAID, has been working to expand proven, 
under-utilized interventions and commodities for PE/E prevention, early detection, and treatment, and to 
strengthen global partnerships and networks for care of hypertensive disorders in pregnancy (HDPs), of 
which PE/E are the severest forms. A systematic review of the literature (the report of which can be found 
at endingeclampsia.org) by the project identifies a number of articles reporting PE/E burdens within set 
populations, common risk factors, adverse outcomes, and mortality rates, but few discuss implementation 
research (IR) to improve PE/E prevention, detection, and timely management.  
Following the literature review and subsequent analysis of antenatal care (ANC) and PE/E in seven Nigerian 
states in 2015, the Ending Eclampsia project began to intensify its activities and IR in Cross River, Ebonyi, 
and Kogi states, emphasizing task sharing with primary health care (PHC) providers for the detection and 
management of HDP including PE/E. (For more information on the baseline data report, described as a 
landscape analysis, please visit www.endingeclampsia.org.) 
This report describes the IR approach of the Population Council in Nigeria from 2016 to 2018 and its 
results, specifically changes in a range of areas including:   
• Policy and programmatic support for PE/E detection and treatment 
• PHC providers’ capacities to identify and manage PE/E 
• PHC provider’s knowledge and competence in preventing, detecting, and managing PE/E, and 
• Communities’ PE/E awareness, beliefs, and experiences. 
Methodology 
The project analyzed the contexts of PE/E awareness and treatment in PHC and secondary health facilities 
selected for the PE/E intervention in Ebonyi, Cross River, and Kogi states, before and after the intervention, 
in collaboration with the Federal Ministry of Health (FMoH) and USAID. This pre-post, cross-sectional design 
integrated qualitative and quantitative data collected at both baseline (2015) and endline (2018).   
Researchers assessed facility readiness and capacities to identify, treat, and manage PE/E at PHC and 
secondary health care levels. The Ending Eclampsia team conducted facility assessments, interviewed 
laboratory staff and care providers who work in ANC, maternity, and labor and delivery wards, observed 
client and provider interactions during ANC consultations, and interviewed pregnant women leaving 
assessed facilities, where the women had received ANC services (i.e. exit interviews). All facilities surveyed 




The project collected data at PHC and secondary facilities from women detected with pre-eclampsia who 
received treatment, and followed them until delivery to determine their maternal and fetal outcomes. 
Survivors of PE/E were also interviewed to understand their individual routes of care before they received 
successful maternity services. Women (18 to 49 years of age) and men (ages 18 to 55) from the local 
communities also participated in focus group discussions (FGDs) for an understanding of their knowledge 
and perceptions of maternal complications including PE/E, and typical routes of care. Data collection also 
included in-depth interviews (IDIs) with national, state and local government areas (LGA) policy-makers.   
TABLE 1   Data Collection tools at baseline and endline  
Three subsidiary IR studies (detailed in separate reports) assessed the feasibility shifting anti-hypertensive 
drug (alpha-methyl dopa) provision to PHC facilities (in Ebonyi and Kogi), the utilization of women’s groups 
platforms to increase community PE/E awareness and use of quality essential maternal and child health 
services (in Cross River), and in seven states—Bauchi, Cross River, Ebonyi, Kano, Kogi, Ondo, and Sokoto—
conducted a hospital-based postpartum follow up study of cohort women and their infants (up to one year 
after delivery) whose pregnancies were complicated by HDPs.  
Intervention 
This study’s primary intervention trained PHC workers, including community health extension workers 
(CHEWs) and nurses/midwives, and provided them with ongoing mentorship, to identify the signs of pre-
eclampsia, administer MgSO4, and refer pregnant women to secondary facilities for continued PE/E 
management. After the initial baseline (pre-intervention) analysis, 180 facilities (36 secondary facilities and 
144 PHC facilities) were purposively selected in three states to participate in the intervention, following 
discussions with each state’s ministry of Health (MoH).  
In conjunction with each state MoH, health care providers were selected for refresher training in PE/E 
management. In every secondary facility included, seven care providers were selected (two ANC nurses, 
two maternity/labor ward nurses, a medical officer, laboratory scientist, and hospital pharmacist). At each 
PHC facility, two CHEWs or community health officers (CHOs) were selected. Each facility received service 
provision manuals, job aids, seed stocks of MgSO4.  
The project and state MoHs conducted mentorship and supervisory visits throughout the intervention, 
strengthening each hospital’s central store commodities logistics capacity. Direct intervention activities 
varied in each state: 24 months in Ebonyi, 18 months in Cross River, and 14 months in Kogi. (The two 
subsidiary IR studies in Ebonyi and Cross River, as well as the postpartum follow up studies, are also shown 
as promising practices tested in Figure 1 on the following page but are reported elsewhere.) 
Core Intervention 
Data collection tools 
Cross River Ebonyi Kogi Total 
Baseline Endline Baseline Endline Baseline Endline Baseline Endline 
Health facility assessments 11 54 20 57 8 60 39 171 
FGDs with men & women 4 4 4 4 4 4 12 12 
IDIs with laboratory staff 4 6 5 6 0 6 9 18 
IDIs with PE/E survivors 5 6 5 6 5 6 15 18 
IDIs with policymakers 10 18 10 18 10 28 30 64 
Observations of ANC visits 15 240 10 119 15 266 40 625 
Exit interviews with ANC women 15 240 10 119 15 266 40 625 
Interviews with PHC providers 59 74 46 89 74 73 149 236 
IDIs with store manager - 11 - 11 - 13 - 35 









Completed questionnaires were transferred to Population Council’s office in Abuja for data entry and 
analysis. Quantitative data analysis, including descriptive, bivariate, and comparative statistics (chi-
squared and Fisher’s Exact tests), used SPSS and STATA; chi-squared tests with more than two levels were 
analyzed using a web platform, Social Science Statistics (www.socscistatistics.com, Kim 2017). In some 
cases, summary scores were generated in STATA to assess multi-component constructs such “Assessing 
risk for PE/E”.  
Qualitative interviews were digitally recorded, supported by field notes, then transcribed and translated into 
English. Content analysis used NVivo software, applying a grounded theory approach at baseline, drawing 
inductively from stakeholder perspectives; at endline, thematic coding applied this codebook to endline 
data, allowing for comparisons over time. Use of multiple methods and perspectives enabled triangulation, 
particularly between observed ANC visits, provider descriptions, and women’s reported experience of care. 
Findings are reported at policy, health system, and community levels. 
Figure 2: Study Reporting Process 
                           
            
 
Ethical Review and Consent Process 
Study protocols for the landscape study of Cross River, Ebonyi, and Kogi were reviewed and approved by 
the Population Council’s Institutional Review Board (IRB) in New York, with additional reviews and approvals 
by the National Health Research Ethics Committee of the Federal Ministry of Health (FMoH) and the ethics 
committees of each state’s MoH. All participants provided informed consent prior to interviews. Before the 
study commenced in 2015, the Council’s research team visited FMoH and state MoH authorities for 
administrative approval, investment, and participation in the study. 
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Demographic Characteristics  
A total of 385 health care providers were sampled in the three states, with a slight increase in the number 
of providers sampled at endline. Surveyed providers’ ages ranged from 20 to 59 years, with an average 
age at baseline and endline of 40 (SD 9.5) and 43 (SD 8.3) respectively. Table 2 (following page) lists the 
characteristics of providers interviewed at baseline and endline.   
While doctors, nurses/midwives, and CHEWs were all interviewed, CHEWs comprised the largest number 
of health care providers in the combined baseline and endline sample. A majority of care providers 
interviewed were females who had been in their current health care provision roles between one and five 
years. 
Observed differences in provider socio-demographics between baseline and endline (see Table 2, page 7) 
could be a result of the slight sample size differences as well as the non-randomized nature of the study, 
which is prone to selection bias. 
Over 80 percent of pregnant women interviewed were between the ages of 20 and 39, with teenage 
pregnancy rate of less than seven percent. Table 3 (on page 8) provides the characteristics of women who 
participated in the exit interviews at baseline and endline.   
Women who participated in interviews were predominantly married or co-habitating (over 90%). Most 
interviewed women are educated, with a secondary or tertiary education (about 80%).  
At endline in Cross River and Ebonyi states, 99 percent of women identified as Christian, whereas in Kogi 
42 percent identified as Christian and 57 percent identified as Muslim (one woman identified as traditional 
or no religion). A mixed religious population in Kogi is to be expected, given its central location between the 




 TABLE 2   Provider Characteristics 
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P-value n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%) 

















202 (85.6) 0.8 



















































































































































P< 0.05 is considered statistically significant 
^Fisher’s Exact Test 






TABLE 3   ANC Client Demographic Characteristics                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
SES, Socio-Economic Status 
 
Characteristics 
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Policy Environment and Stakeholder Support for PE/E Improvement  
Policy-makers in Cross River, Ebonyi, and Kogi understand that women in their communities face a range 
of maternal health challenges. Stakeholders—from the LGA to national level—support strengthening access 
and use of under-utilized services, especially ANC services, to reduce their communities’ PE/E burdens. 
Following the baseline survey in 2015, policy-makers acknowledge the importance of early ANC registration, 
lending important political support to the goal of improving maternal health outcomes in pregnancies 
complicated by PE/E.  
“The question is about going for antenatal [care] early enough at six weeks, at eight weeks, isn’t 
it? This is what we are preaching about pregnancy and management of pregnancy [nowadays]”.                                
Policy-maker, Kogi, 2015 
Policy-makers understand that low ANC utilization is often related to structural and other barriers, including 
poverty, transportation and health care costs, and lack of education, or awareness.  
“During first registration they come in enough [in large numbers] but [for] subsequent visits, most 
of them don’t come back…that is one of our greatest challenges.”  
LGA health manager, Cross River State, 2018 
“Poverty is the predominant problem that we have, and other problems we have are illiteracy…and 
ignorance. Now, these three problems have gone a long way to affect a lot of pregnant women; for 
instance, because of illiteracy some of them don’t know that it is important to attend antenatal 
care and because of poverty even those who know that it is important to attend antenatal care 
may not have the money to attend antenatal care. Even those of them that attend [ANC], because 
of poverty, they may not have the money to do the basic lab investigations that the doctor or the 
health worker has prescribed. That has gone a long way to affect the maternal morbidity and 
mortality.”                                                                                             State policy-maker, Ebonyi, 2018 
In at least one state, there is evidence that local policy stakeholders are not aware of the latest WHO 
recommendations for number of ANC contacts for a healthy pregnancy, which increased from four to eight 
(WHO 2016). As local leaders are charged with ensuring women within their LGAs receive adequate and 
timely care, mis-information represents a barrier to women’s health care needs, and may reflect 
information disparities between national and lower government levels. Additional information disparities 
were seen in endline interviews, with policy-makers offering mixed and conflicting information about 
Nigeria’s national protocol for PE/E management: Some were aware of the policy, others were not—yet all 
showed interest and support for rapid dissemination and implementation of existing policies. Even among 
state policy-makers familiar with the national PE/E protocol, knowledge of its implementation within local 
communities was sparse. Knowledge of the policy’s implementation was particularly low in Kogi, with most 
local and state policy-makers either never having heard of the protocol or not having read it.   
“In one of the policies it has been emphasized to us that when we have such cases [PE/E] we 
should attend to them promptly; we don’t demand for anything first. The government really 
emphasizes that we have to attend to them promptly, not minding the financial aspect.”  
LGA Health manager, Cross River, 2018 
“I don’t have an idea, but I know it might exist (the policy guideline). They should disseminate the 
protocol now, let us see it. Maybe the physicians have seen it, but as a logistician and a pharmacist, 
I have not seen the protocol. I will be glad to have a copy.”             State policy-maker, Ebonyi, 2018 
“I am not aware of it [the national protocol]. I’m sorry, I want to be frank.”  





Increased knowledge at lower levels, at endline compared to baseline, of the national PE/E guidelines 
suggests that these guidelines, as important strategies for managing PE/E, are steadily reaching state and 
local policy-makers. While communication on the importance of strengthening PE/E management through 
effective policy implementation is improving, the mechanisms remain tenuous. Despite these challenges, 
policy-makers are dedicated to developing pragmatic solutions for maternal health challenges in their 
communities, including partnerships with existing community leaders and NGOs, to mitigate structural 
barriers such as transportation.  
“It is [ANC] a problem that we are trying to correct. We discovered that fault in almost all the 
facilities, that first ANC is always greater than ANC 2, 3, or 4, because a woman is supposed to 
visit the clinic four times before she delivers. We looked at ANC generally in Cross River State, and 
we discussed with service delivery international non-governmental organization, after we had 
meetings with the chief, the youth leaders, women leaders, and other people in the ward; we have 
all agreed because they told us one major challenge is transportation to the clinic. So, any woman 
that wants to deliver anywhere—now we have provided transport.”  
LGA Health manager, Cross River state, 2018  
Progress in strengthening PHC facilities and enabling their workers to detect and treat PE/E using MgSO4 
prior to referral has been made in all three states. Specific policy-maker knowledge of Nigeria’s national 
task shifting protocol, specifically for PE/E management among lower cadres, was mixed: State policy-
makers knew more than LGA officials. Nearly all policy-makers support task shifting to PHC workers 
because they recognize the structural barriers women face for timely PE/E care at secondary or tertiary 
levels. According to policy-makers, a national effort has begun to re-vitalize the PHC system, by ensuring at 
least one PHC facility per ward is fully functional at all times, including 24 hour water supply and electricity, 
and sufficient personnel to meet clients’ health needs. 
“Task shifting is a welcome development because we only have a few nurses in the LGAs, so the 
task should be shifted from nurses to other health care workers so that if the nurse is not there at 
the community level to administer, it doesn’t mean the patient should die.”  
Policy-maker, Cross River, 2018 
While at baseline policy-makers (particularly in Ebonyi) were only moderately supportive of task shifting, 
citing concerns about insufficient PHC provider knowledge, training, and capacities, at endline policy-
makers acknowledged the successful role of this intervention’s training in improving PHC providers’ skills 
and establishing an effective treatment option for women.  
“It depends on the capacity of the staff in primary care center because magnesium sulphate is not 
something anybody can administer…we only allow magnesium sulphate to be administered by 
midwives and registered nurse/midwives.”                                                 Policy-maker, Ebonyi, 2015 
“At the facility level, the trainings that these health workers received have really empowered them; 
their capacity has been built…in 2015 many of them did not know what magnesium sulphate was 
but now in all the health facilities, the majority of the people trained can manage pre-eclampsia. 
They notice the warning signs; they give the loading dose and then refer.” 
State policy-maker, Ebonyi, 2018 
At baseline, national MgSO4 procurement and distribution was largely unclear, with multiple, parallel state 
and federal procurement systems in addition to the private sector. The situation is now gradually improving. 
According to state policy-makers at endline, a new federal revolving fund enables secondary health facilities 
to purchase drugs directly from pharmacies to prevent stock outs. This revolving fund is not available to 
PHC facilities, which receive essential medicines and equipment, including BP machines and urine 
dipsticks, either directly from the government or through public-private partnership support, from NGOs or 
other private donors. State policy-makers report that essential medicines including MgSO4 are also 




“The government is providing, in conjunction with partners like Pathfinder and UNFPA—they are 
buying and procuring all these blood pressure apparatuses, which I know they try to provide to 
those facilities.”                                                                            State policy-maker, Cross River, 2018 
“The state has to make sure we have it in stock. I think the pharmacy department can talk more 
on that because [MgSO4 ] is one of the essential drugs that the government is supposed to provide 
every quarter, using what they call DDIC that is, direct delivery inventory system, so as they’re 
delivering, they are taking inventory of what is available so that you know when to deliver next. I 
don’t think stockouts are still a problem for this state.”                   State policy-maker, Ebonyi, 2018 
Despite reported commodity availability and procurement options within states, local Cross River and 
Ebonyi policy-makers report frequent drug stock outs at tertiary and secondary facilities, citing lack of 
government financial support for drug purchases as the primary cause. In Kogi, strong NGO support for 
drug and supply procurement largely prevents stock outs, even at PHCs.  
In all three states, and at all levels, policy-makers describe a variety of procurement mechanisms, from 
health facility purchases from community pharmacies, to individual patient purchases, to supplies from 
NGOs, with little evidence of coordinated efforts to ensure consistent supply. Additional progress is needed 
to synchronize national and state procurement processes, with coordination between the public and private 
sectors, to capitalize on the growing political interest throughout Nigeria for improved PE/E management.  
Health System  
Provider knowledge of PE/E prevention  
Health care providers were asked about their knowledge of pre-eclampsia risk factors including chronic 
hypertension, obesity, pre-existing diabetes or diabetes in pregnancy, maternal age (≥35 years or <20 
years), sickle cell disease, PE/E history, kidney disease, and connective tissue diseases (Table 4). CHEWs’ 
abilities to diagnose eclampsia improved at endline (p=0.001), but there was no significant improvement 
in their ability to diagnose chronic hypertension and severe pre-eclampsia.  
PHC providers in all three states improved their abilities to diagnose eclampsia (p<0.001). Providers who 
reported training on maternal or child health or family planning (FP) also showed significant improvements 
in their ability to diagnose HDPs, from baseline to endline (p<0.001).  
No statistically significant differences were found among providers based upon their length of service in 




TABLE 4 Provider abilities to diagnose chronic hypertension, severe pre-eclampsia, and eclampsia 
Case Studies – Diagnosis pf chronic hypertension, severe preeclampsia and eclampsia in all three states 
  Chronic hypertension in pregnancy1 
(Baseline, Total n=149; 
 Endline, Total n=236) 
Severe Pre-Eclampsia2 
(Baseline, Total n=149; 
 Endline, Total n=236) 
Eclampsia3 
(Baseline, Total n=149; 
 Endline, Total n=236) 
  Correct diagnosis (n=169) Correct diagnosis Correct diagnosis 












Type of Provider, n (%)* 
Doctors (BL = 21; EL= 7)  18 (85.7) 4 (57.1) 0.1† 19 (90.5) 7 (100.0) 0.9† 20 (95.2) 7 (100.0) 0.9† 
Nurse/Midwife  
(BL = 71; EL = 78) 
36 (55.4) 34 (43.6) 0.2 60 (87.0) 77 (99.0) 0.006† 62 (88.6) 77 (98.7) 0.01† 
CHEW, CHO, Others (BL= 57, EL = 149) 19 (35.9) 58 (38.9) 0.7 44 (80.0) 133 (88.1) 0.1 40 (71.4) 136 (90.1) 0.001 
Missing/No response 10 2  4 0  2 0  
Facility Type, n (%)* 
Tertiary (BL =4; EL =0) 2 (50.0) 0 (0.0) - 3 (75.0) 0 (0.0) - 3 (2.0) 0 (0.0) _ 
Secondary (BL = 82; EL = 62) 48 (62.3) 28 (45.9) 0.05 70 (87.5) 60 (96.8) 0.07† 75 (93.8) 62 (100.0) 0.07† 
Primary (BL = 63; EL = 174) 23 (39.7) 68 (39.3) 0.9 50 (82.0) 157 (90.2) 0.09 44 (69.8) 158 (90.8) <0.001 
Missing/No response 10 2        
Years working in present unit/ward, n (%)* 
<1yr 22 (33.3) 19 (20.4) 0.16 
  
26 (23.6) 48 (22.4) 0.2 
  
29 (26.6) 48 (22.1) 0.41  
1-5yrs 26 (39.4) 40 (43.0) 52 (47.3) 83 (38.8) 46 (42.2) 86 (39.6) 
>5yrs 18 (27.3) 34 (36.6) 32 (29.1) 83 (38.8) 34 (31.2) 83 (38.3) 
Missing/No response 7 3 13 3 13 3 
Any training on maternal health, FP or child healthcare, n (%)* 
Yes 37 (50.7) 93 (97.9) <0.001† 59 (48.0) 206 (96.3) <0.001 56 (45.9) 208 (95.9) <0.001 
No  36 (49.3) 2 (2.1) 64 (52.0) 8 (3.7) 66 (54.1) 9 (4.1) 











1  A pregnant woman presents at 12 weeks with BP 160/100 mmHg with no proteinuria 
2  A pregnant woman presents at ANC at 30 weeks with BP 180/115mmHg and proteinuria of 2++ 




The Pritchard regimen for MgSO4 administration to prevent and treat convulsions for severe PE/E is 
generally preferred and recommended in low resource settings, including Nigeria, for its ease of use. The 
Pritchard regimen employs both an intravenous (IV) loading dose and intramuscular (IM) maintenance 
doses. To successfully shift MgSO4 administration for PE/E treatment to PHC workers, this intervention 
implemented a modified Pritchard method of an IM 10mg MgSO4 loading dose only, with referral to a 
secondary facility for maintenance doses. Only 12 percent of providers knew the correct loading dose of 
MgSO4 at baseline, but 78 percent knew the correct loading dose at endline, a more than six-fold increase 
(p<0.001). 
TABLE 5 Correct knowledge of MgSO4 loading dose for PE/E (modified Pritchard Regime 10mg IM) 
  Ebonyi Cross River Kogi All  
  Baseline Endline Baseline Endline Baseline Endline Baseline (n=149) 
Endline 
(n=236) p-value 




5 10.9 71 79.8 6 10.2 56 75.7 7 15.9 58 79.5 18 12 185 78 <0.001 
Total 46 100 89 100 59 100 74 100 44 100 73 100 149 100 236 100  
Provider practices for preventing PE/E 
Observations of ANC consultations assessed provider practices (see box below) for PE/E prevention, 
detection, and complication avoidance. Findings from observation data (Table 6) show that providers 
frequently measured patients’ blood pressure (BP) and proteinuria, but less often assessed or 
communicated patients’ risk for pre-eclampsia. At endline, less than one third (29%) of all providers offered 
information when recognizing signs of impending eclampsia (severe pre-eclampsia) with women, although 
nearly half (45%) of providers in Kogi did. At baseline, however, no providers provided patients any 
information about symptoms of impending eclampsia—making the endline results cited evidence of marked 
improvement at endline, in all three states. At both baseline and endline, in all three states, more pregnant 
women had physical examinations for pre-eclampsia instead of providers assessing pre-eclampsia risk and 
advising on symptoms of impending eclampsia. 
TABLE 6 Observations of client and provider interactions  

















n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%) 






















































Definitions Used for ANC Consultation Observations 
Assessing risk of pre-eclampsia: History of hypertension/high BP, history of diabetes, asked about 
date of last delivery, client weight, pregnancy order, and client age 
Detecting pre-eclampsia: Client’s BP and urinalysis (protein/albumin) 
Advising on symptoms of impending eclampsia: Severe headache, blurred vision, high BP,  




For the seven total variables that measured provider practices for assessing pre-eclampsia risk, summary 
scores for each observation show the number of variables actually exhibited (0 representing no risk 
assessment observed, up to 6 representing all six variables assessed). While there were overall 
improvements in provider assessments of two to three risk factors at endline, there appears to be lesser 
improvements for provider assessments of all six risk factors. The two most frequently assessed factors at 
endline were client weight (94.4%), and age (53.3%); questions around hypertension, diabetes, and last 
delivery were less frequently asked (23% to 30%). 
Figure 3 Pre-eclampsia risk assessment scores observed during ANC client-provider interactions 
 
Summary scores for each observation show whether or not a provider correctly checked for pre-eclampsia 
(up to 2 indicators), including BP and proteinuria testing, at baseline and endline (dis-aggregated by state). 
A clear and significant improvement in measuring at least one, as well as both, was observed overall, in 
each state, suggesting that the primary intervention’s emphasis on early detection and management was 
successful, although more so with BP checks (97.1%) than proteinuria testing (69.3%) (data not shown).   
Figure 4  ANC observation summaries of pre-eclampsia detection scores  
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Kogi Endline (N = 266)
Proportion of ANC  Observations





Four variables measured provider practice on advising women with severe pre-eclampsia symptoms to 
prevent eclampsia and other complications. Summary scores generated for each observation show the 
aggregate number of symptoms on which advice was provided (0 representing none, up to 4 representing 
advice for all 4 symptoms).  
Results are mixed on provider advice on different pre-eclampsia symptoms; while some providers at endline 
still did not advise on any symptoms, quite a few provided advice on all four symptoms. The relative 
consistency of this pattern in all three states likely reflects the challenges in PHC provider attrition or 
transfers, which may have limited the reach of training and mentoring within the primary intervention. At 
endline, improvements for all symptoms were seen: Severe headache was the symptom most frequently 
advised (58.2%), followed by high BP (49.4%), then generalized body swelling (45.4%), and blurred vision 
(41.7%). In Kogi state no provider at baseline advised on any sign or symptom of severe pre-eclampsia. 
Figure 5 ANC observation summaries of symptom advice scores 
 
Detection and management for pre-eclampsia: monitoring data 
In the primary Ending Eclampsia intervention, PHC providers were trained and mentored to pro-actively 
document their process of pre-eclampsia detection for timely management, including delivery and referral 
if appropriate. This documentation allowed the project to monitor how women were diagnosed and 
managed.  
High risk pregnancies related to age, defined as pregnant women ages 15 to 19 and over 35 years, were 
relatively common (5.7% and 21.6%, respectively). Among women whose BP was recorded at registration 
(153 women), nearly one half were already hypertensive. The medical histories of this cohort reveal low 
proportions of risk factors associated with pre-eclampsia, such as history of hypertension, diabetes, or 
previous pre-eclampsia. Late ANC registration was common: Only about 7.3 percent of women registered 
for ANC in their first trimester. 
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TABLE 7 Characteristics of Pregnant Women Enrolled with PE/E—All States  
Characteristics 








n (%) n (%) n (%) n (%) 
Age                                           15 – 25 
>25 – 35 




























































































































































































          GA, Gestational age; CS, Caesarean section, PE/E, Pre-eclampsia/Eclampsia 
               †includes formerly married (divorced, widowed). 
  
At enrolment in this study, 20.5 percent of women were diagnosed with pre-eclampsia, 74.4 percent with 
severe pre-eclampsia, and 3.4 percent with eclampsia. Only 61.8 percent of those diagnosed with severe 
pre-eclampsia received MgSO4, perhaps due to health system limitations such as stock outs.  
Referral trends among women diagnosed with pre-eclampsia and severe PE/E differed by state: Women in 
Ebonyi were more frequently referred to higher level facilities for follow up care. Of the 176 women enrolled, 
only 130 had their gestational age recorded at delivery, and among those women, 53.9 percent delivered 
pre-term (less than 38 weeks) and 46.1 percent at term (≥38 weeks). Similarly, 154 of the 176 women 
with pre-eclampsia had their mode of delivery documented: 45.4 percent had a Caesarean delivery, 44.2 
percent had spontaneous vaginal delivery, and 10.4 percent were induced for vaginal delivery. State 





TABLE 8 Diagnosis and management on enrollment among monitored women  








n (%) n (%) n (%) n (%) 




















Received MgSO4 upon severe pre-eclampsia diagnosis  
at enrollment* 42 (66.7*) 22 (57.9*) 17 (56.7*) 
81  
(61.8*) 
Referred from PHC on enrollment                                       Yes 15 (18.5) 24 (43.6) 5 (12.5) 44 (25.0) 















Mode of delivery                                                Vaginal delivery 



















*Proportions of women diagnosed with severe pre-eclampsia at enrollment (N=63, 38, 30, 131 in Cross River, Ebonyi, Kogi, and Total, respectively) 
Maternal outcomes (dead or alive) were recorded for 157 of the 176 women who were followed until 
delivery. Among those, 96.8 percent of mothers survived, with 3.2 percent recorded as maternal deaths. 
Available mortality information (n=34) reveal stillbirths and early neonatal deaths for 50 percent of the 
infants. Infant death records were more consistently recorded in Ebonyi. 
Table 9 Pregnancy outcomes among monitored women  








n (%) n (%) n (%) n (%) 






























Fetal death by category, n (%) (n=11) (n=19) (n=9) (n=39) 
Dead (not categorized) 
Stillbirth 


















Commodity and supply chain for emergency hypertension management  
Health facility assessments 
At endline, nearly three quarters of facilities stocked anti-hypertensive drugs and MgSO4, significantly more 
than at baseline (p<0.001). Despite it being a non-significant increase, the proportion of facilities stocking 
calcium gluconate to treat MgSO4 toxicity increased from 13 percent to 70 percent from baseline to endline. 
Patella hammers (used to test knee reflexes, a sign of toxicity) were infrequently found both at baseline 


























n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%) 
Anti-hypertensives 1 (5.0) 37 (64.9) 0 (0.0) 25 (46.3) 3 (37.5) 49 (81.7) 4 (10.3) 111 (65.0) 
MgSO4 5 (25.0) 47 (82.4) 5 (45.5) 28 (52.0) 2 (25.0) 47 (78.3) 12 (30.8) 122 (71.3) 
Calcium 
Gluconate 2 (10.0) 44 (77.2) 2 (18.2) 34 (63.0) 1 (12.5) 41 (68.3) 5 (12.8) 119 (69.6) 
Patella Hammer 1 (5.0) 5 (8.8) 0 (0.0) 14 (25.9) 1 (12.5) 5 (8.3) 2 (5.1) 24 (14.0) 
Urine Catheter 9 (45.0) 23 (40.3) 5 (45.5) 32 (59.3) 5 (62.5) 40 (66.7) 19 (48.7) 95 (55.6) 
Urine Bag 3 (15.0) 15 (26.3) 4 (36.4) 16 (29.6) 4 (50.0) 24 (40.0) 11 (28.2) 55 (32.2) 
Facility capacities for EmONC signal functions, and records of them, in the previous three months 
(dependent on stock and need) remained fairly constant—and mixed—between baseline and endline (Table 
11). Improved capacities were reported for stocking parenteral antibiotics, oxytocics, MgSO4, and neonatal 
resuscitation equipment. Facility administration of parenteral antibiotics and neonatal resuscitation, in the 
preceding three months, also increased at endline. Disparities between facility reports of EmONC capacity 
compared with actual practice, in the preceding three months—at both baseline and endline—corresponds 
with the primary intervention’s lack of focus on comprehensive EmONC, except for MgSO4. 
TABLE 11 Signal Functions for EmONC 











Within past 3 
months  
n (%) 
Within past 3 
months  
n (%) 
Parenteral antibiotics 30 (77.0) 146 (85.3) 25 (64.1) 120 (70.2) 
Parenteral oxytocics 32 (82.1) 151 (88.3) 31 (79.5) 134 (78.4) 
Parenteral anticonvulsants (MgSO4) 18 (46.2) 115 (67.3) 13 (33.3) 48 (28.1) 
Manual placenta removal 32 (82.1) 135 (79.0) 20 (51.3) 80 (46.7) 
Retained products removal 27 (69.2) 115 (67.3) 23 (59.0) 63 (36.8) 
Assisted vaginal delivery 27 (69.2) 88 (51.5) 21 (53.8) 72 (42.1) 
Blood transfusion 18 (46.2) 56 (32.7) 15 (38.5) 35 (20.5) 
Caesarean section 12 (30.7) 30 (17.5) 11 (28.2) 21 (12.3) 
Neonatal resuscitation 25 (64.1) 138 (80.7) 18 (46.2) 98 (57.3) 
Drug store manager survey findings 
Although the project did not interview drug store managers at baseline, it became evident during 
implementation that essential commodities and medicines to manage PE/E were not being procured by 
secondary facilities. Following discussions with state MoHs, a one day workshop for drug stores and 
pharmacy workers was presented on specific maternal health commodities. As a result, 35 drug stores 
managers at secondary health facilities  (11 from Ebonyi, 11 from Cross River, 13 from Kogi) were 
interviewed only at endline to understand supply and commodity availability and logistics management 
practices for pre-eclampsia treatment (data not shown). Most drug stores managers were between 40 and 
49 years of age, 60 percent were male, and most were pharmacist technicians (54.3%), and then 
pharmacists (42.9%) or pharmacy technologists (2.9%). Just under two thirds (62.9%) of drug stores 




Although the project provided supply chain logistics support training, some drug stores managers (28.6%) 
reported lack of training in medicine management within the last 12 months. Moreover, only 40 percent 
said they had received any training on EmOC.  
A majority of the trained drug store managers (88.6%) said they did not have sufficient opportunities to 
practice what they had learned, and think more practical sessions are required to build their confidence. 
All drug stores managers were familiar with medicines for preventing and treating eclampsia convulsion 
and are aware that they are on the essential drug list. Most (82.9%) drug stores managers could recall 
storage guidelines for MgSO4 and calcium gluconate, while around two thirds (65.7%) said they personally 
manage stocks of uterotonic and pre-eclampsia medicines.  
Community Perceptions and Understanding of PE/E 
Understanding of the causes of PE/E within communities largely improved since baseline. At baseline, PE/E 
symptoms and causes of HDP were attributed to spiritual attacks, evil spirits, and witchcraft, and those 
associations were less prevalent at endline, particularly in Cross River and Ebonyi. In Kogi, community 
members emphasized religious leaders’ influences in reinforcing the belief that HDP and other PE/E 
symptoms are caused by spiritual attack. Despite these misperceptions, community members in all three 
states knew that ANC registration is integral to a healthy pregnancy as well as PE/E prevention and 
management. Although the men interviewed did accompany their wives to ANC visits, they reported 
encouraging ANC registration. Women in FGDs reported, however, that their husbands are most likely to 
take their wives to hospitals, instead of traditional birth attendants (TBAs), in cases of pregnancy 
complications.  
Health system trust among community members improved significantly in all the three states, with 
community members (including husbands and mothers-in-law) emphasizing the importance of facility-
based care and ANC registration to address pregnancy complications.  
“They normally go to see doctors or nearest health facility to seek care. This is because they have 
learnt that it is proper and important to see a doctor to check them and their unborn baby.” 
Female FGD participant, Ebonyi, 2018 
Traditional health care elements still exist in all three states, but community members described these as 
complementary to the formal health system, rather than functioning in opposition to it. In Ebonyi religious 
leaders and TBAs are not directly involved in the formal health system, and at endline FGD participants less 
frequently mentioned TBAs as a woman’s primary delivery preference, which suggests that these traditional 
health-seeking practices are becoming less common as women and communities begin to trust and engage 
more frequently with the formal health system.  
In Kogi and Cross River, community members described some women as seeking facility-based care, while 
others continue to prefer traditional healers. Community members in these states report that religious 
leaders’ primary influences upon women’s health-seeking behaviors are through prayer and the delineation 
of the distinct roles of traditional caregivers and the formal health system as complementary in women’s 
health and pregnancy care.  
“The religious leaders concern themselves only to praying for women with health problems, but the 
restriction is that they cannot transfuse blood into a woman who needs blood, which is done only 
at the hospital. If the religious leader does their part, the hospital likewise has its own part.” 
Female FGD participant, Cross River, 2018 
“They [church leaders] also help in other means like if there is any program being proposed by the 




Overall, community members support pregnant women’s health care-seeking and offer emotional and 
material support whenever possible. Although men are concerned with the costs of their wives’ ANC and 
hospital care, they stressed the importance of being a supportive husband and ensuring their wives receive 
adequate care during pregnancy. Many mothers-in-law equally encourage their daughters-in-law to seek 
facility-based care, although some Kogi community members report dismissive attitudes of some mothers-
in-law, who describe their daughters-in-law as simply ‘lazy’ or ‘pretending’ to have hypertensive symptoms.  
“Some mother in-laws [sic] would be happy; they would even pamper the daughter in-law. On the 
other hand, there are mother in-laws that would feel that the daughter in-law is too lazy. If you 
suggest going to the hospital, some mothers could say the pregnant daughter in-law just want to 
waste their sons' money. At that point they'd start suggesting home remedies.”  
Female FGD participant, Kogi, 2018 
“Our mother in-laws [sic], since many…don’t live with us in the house, they know these problems 
through us. When my wife is pregnant, even though I am going far, I make sure when I am back I 
stay around her, and discuss with her closely how she is feeling, and if I observe anything I try to 
inform my mother in-law because she is a mother, so that she can advise on the next line of action.”  
Male FGD participant, Cross River, 2018 
“We need to tell women the importance of prenatal care and give them financial support. But the 
main thing is to tell them the importance of it.”                            Male FGD participant, Ebonyi, 2018 
Inability to attend ANC or seek facility-based care are attributed to financial barriers, specifically hospital 
bills and treatment costs, rather than transportation costs, ignorance of the importance of ANC, or 
continuing preference for traditional birth practices. At baseline, community stakeholders blamed lack of 
transportation support and ignorance more than at endline. In at least one community in Cross River, the 
distance to health facilities and access disparities among women living closer to the main road and those 
farther affected women’s care-seeking behaviors.  
“Well if my wife complains problem and I take her to the hospital, you know those pharmacy 
Doctors complain too much about money, if am a man and am working, there is no complaint she 
will give that will not be able to solve because she is my wife and I love her.” 
Male FGD participant, Cross River, 2018 
“My view as the man of the house is that the government loves us so much by sending you as a 
facilitator over this program, the government should not only send you to come and gather ideas 
from us, the government should also see what we are discussing and make these things available 
to our women.”                                                                         Male FGD participant, Cross River, 2018  
Persistent community perceptions of insupportable personal expenditures as barriers to care are of deep 
concern, considering policy-makers’ earlier descriptions of pregnancy complication care as low cost or free. 
PE/E Survivor Experiences 
At baseline, over half of PE/E survivors said they first registered for ANC only when they began experiencing 
complications or adverse symptoms during pregnancy. At endline, not only did all survivors interviewed 
register for ANC prior to complications, more than 83 percent reported registering because they knew that 
contact with a formal ANC clinic is important for healthy pregnancy. Many women reported at least four 
ANC contacts (range 1 to 10+), although survivors continue to report delayed registration, nearly always 
after the first trimester. One survivor registered at two months’ gestation and attended eight ANC sessions; 
a second survivor reported visiting a hospital at two months’ gestation to confirm her pregnancy but chose 
not to formally register for ANC until her fourth month of pregnancy, citing her desire to maintain the 




“O.K., it was, it was fine, it was great because I never wanted people, I went there when it was two 
months and I never let people know, the workers there…they talk a lot, they might say ‘Oh! This 
person has registered with us, she is pregnant.’ So, I didn’t, I told doctor that they should just run 
a test, but he should have his record, when I come, when I am three or four months then I can now 
come and register with them. So that was what they did.”               PE/E Survivor, Cross River, 2018 
“I knew I was supposed to register even without any problems, I know it so that was why I went 
there to register.”                                                                                  PE/E Survivor, Cross River, 2018 
“I can’t really recall but I have been going there monthly, I registered at four months, then have 
been going there monthly then by eight months, eight months getting to nine months was now 
weekly.”                                                                                                  PE/E Survivor, Cross River, 2018 
As at baseline, urine and BP are routinely checked during ANC visits, and women’s reports corroborate 
observational findings that multiple key components of ANC are now routine, including abdomen checks 
and fetal heartbeat monitoring. Women in all three states at endline consistently received both urine and 
BP checks and test results—an improvement from baseline—and women are knowledgeable about what 
constitutes dangerous BP and proteinuria levels.  
“The blood pressure started from 165 when they noticed [pre-eclampsia]. That day I just went for 
ANC and after checking the blood pressure [it was high] it started from 165 and before delivery it 
ran to 195 over 140.”                                                                                   PE/E Survivor, Ebonyi, 2018 
While women and providers increasingly dialogue about women’s test results as PE/E symptoms occur, in 
all three states few women reported thorough explanations about the implications of their results, despite 
asking for more information. One survivor described better quality information in her first pregnancy than 
during her second when she attended ANC at a different hospital, suggesting that provider-patient 
discussions, beyond strictly clinical test results, vary by location.  
Women in all three states are more aware than ever of the importance of ANC for healthy pregnancies, and 
many women are interested in learning more during their ANC visits, evidenced in part by the 50 percent 
of women who actively asked questions during their observed ANC appointments.  
“You know that they do not tell us all these things in all the hospitals. I know what you are talking 
about. During my first pregnancy, I went for antenatal in Uburu; those people will teach you all 
these things and make you to understand them all.”                                PE/E Survivor, Ebonyi, 2018 
“He did not tell me what they saw in my urine. I asked so that they will explain to me, but they did 
not. I think they told my husband, I will ask him later. I was not told [the implications], but I was 






This report describes results of a pre-post intervention to build the capacities of PHC providers for managing 
PE/E at lower levels of Nigeria’s health system. An important approach for preventing deaths and severe 
morbidities from pre-eclampsia is PHC providers’ abilities to detect pre-eclampsia early and take 
appropriate action, including infant delivery or prompt referrals when indicated.  
For this PHC model to work effectively, health care facilities must be supported by regular essential 
commodity (MgSO4, anti-hypertensive drugs, urine dipsticks, calcium gluconate) and equipment (BP 
measuring machines and patella hammers) supplies. Women should also be given opportunities to ask 
questions about their and their infants’ health during ANC and PNC consultations. Active community 
engagement with women, through various social platforms, should motivate women to take charge of their 
health and seek relevant care from facilities in a timely manner. This project’s interventions addressed 
these aspects together, under the PE/E PHC model of care that was tested.  
Provider abilities for routine assessment of pre-eclampsia improved, along with its management according 
to current WHO recommendations for PE/E prevention and treatment (WHO 2015). At baseline, no provider 
proactively checked for pre-eclampsia. Although progress was marginal, given HDP prevalence in Nigeria 
the impacts of this study’s progress, if scaled nationally, would be large, as PHC providers trained now have 
the capacity to detect and manage pre-eclampsia and administer loading doses of MgSO4 in appropriate 
cases (Danmusa, Coeytaux, Potts, Wells 2016, Khandekar, Patil, Pawar, Rajgure, Suryavanshi 2011, 
Oguntunde et al. 2015). 
This project engendered new energy and commitment, with consistent and strong support from policy-
makers to extend task shifting to PHC providers for MgSO4 loading doses and referrals. The immediate 
benefit of this policy shift, and the supportive environment, was demonstrated through PHC providers’ 
proven capacities to detect, treat, and manage HDP and PE/E by administering MgSO4 loading doses using 
a modified Pritchard regimen of 10mg MgSO4 (in conjunction with other treatment and timely delivery) and 
referrals. The original Pritchard regimen is based on a loading of 14g, divided into 4g IV and 10g IM (5g in 
each buttock), and this modification eliminates the initial 4g IV dose and only provides the 5g IM doses, 
making it simpler and more convenient to administer in a PHC setting, where providers have less experience 
in IV medicines. Other studies and countries use this modified dose (Bangladesh, CLIP Trials). WHO is 
leading work on understanding the actual sufficient minimum MgSO4 loading and maintenance doses 
(Okusanya et al. 2016).  
Building the capacity of PHC providers to better diagnose HDP and provide prompt care based on its type 
and severity is a major advance for how HDP is managed in Nigeria and a contributor to overall improvement 
in HDP care in Nigeria. Before now, the local task shifting policy only referenced provision of MgSO4 loading 
dose at a PHC facility, while remaining silent on HDP management. Other studies have reported the success 
of this approach (FMoH 2014, Singh, Ahmed, Egondu, Ikechukwu 2014, Townsend, Brien, Khalil 2016).  
While communication of the importance of strengthening PE/E management through effective policy 
implementation has improved, the mechanisms remain somewhat tenuous. Despite challenges, policy-
makers are dedicated to developing pragmatic solutions to maternal challenges in their communities, 
including partnerships with both the private and non-profit sectors. Progress has been made in all three 
states for strengthening PHC systems and enabling their workers to manage and treat PE/E using MgSO4. 
Specific knowledge of Nigeria’s national task shifting protocol for PE/E management to lower health care 




Nearly all policy-makers support task shifting to PHCs due to the structural barriers women face in 
accessing timely PE/E care at secondary or tertiary facilities. According to policy-makers, a national effort 
to revitalize the PHC system has begun, for ensuring at least one fully functional PHC facility per ward at all 
times, including 24 hour running water and electricity, with sufficient personnel. Stock outs in essential 
maternal health commodities such as MgSO4, calcium gluconate, and anti-hypertensive drugs were 
reduced, with the proportion of health facilities with MgSO4 stock outs falling from 70 percent at baseline 
to 21 percent at endline, a major advance in ensuring access to prompt EmOC, especially at PHC facilities, 
and increasing use of under-utilized life-saving maternal and child health commodities (WHO 2011, Tukur 
2009). Linking health facilities to the UNFPA supply chain, along with training logistics managers, may have 
contributed to this improvement. The project also acknowledges the contribution of Saving Mothers Giving 
Life and the Global Health Supplies Chain projects for their collaborations to this feat in Cross River and 
Ebonyi. This collaboration underscores the call for partnership and support assertion that a multi-sectoral 
action is required to strengthen commodity supply chain for maternal health (Juma et al. 2018).  
Despite the success in building the capacities of lower cadre health care providers to detect and manage 
PE/E, along with immediate improvements in supply chain processes, inconsistent and shifting funding will 
continue to negatively affect commodity supply and procurement procedures for essential tools and 
commodities, impeding the ability of trained providers to detect and manage PE/E in particular, and provide 
quality ANC, intrapartum care, and PNC services in general. These types of sustainability concerns have 
been emphasized elsewhere (Rawlins et al. 2018).  
Global and national guidelines for managing PE/E are still not routinely communicated to sub-national 
health officials, contrary to global standards and recommendations (WHO 2014). Where such guidelines 
are found at sub-national levels, they are not maximally utilized. Future efforts should focus on ensuring 
global and national guidelines are promptly transmitted and adopted for sub-national use where problems 
exist.  
Improvements were observed at community and policy levels. At endline, community members and policy-
makers understood that a woman’s risk of PE/E and other pregnancy-related complications can be 
mitigated through early ANC registration and regular attendance. There is accompanying community and 
political momentum for bolstering improvements in early ANC registration in the states where Ending 
Eclampsia intervened. One aspect of ANC services that future programmers and researchers should 
address in low- and middle income countries, including Nigeria, is early ANC registration (Dahiru and Oche 
2015, Fagbamigbe and Idemudia 2015, McKenzie, Abdulwahab, Sokpo, Mecaskey 2016). 
Pregnant women must register for ANC early, at the latest by the end of their first trimester, so health care 
providers can apply available guidelines, for their optimal care. If the women in this study each were 
registered for ANC early, their pregnancies, diagnoses, clinical management, referrals, and maternal and 
fetal outcomes would have shown greater improvements than these observed in this PHC PE/E model 
intervention. Only 26 percent of women had registered for ANC before 20 weeks’ gestation, and nearly half 
of women were already hypertensive at their first ANC visit, and three quarters of those with severe pre-
eclampsia. This situation provides little time for meaningful interventions to save lives. 
Kogi was the only state in which IR on additional interventions was not conducted (women’s group study 
and testing the feasibility of CHEW HDP diagnosis and management); in Cross River, women’s group leaders 
were trained in PE/E health education for their groups, while in Ebonyi PHC providers received 
supplemental training on diagnosing and managing HDP, including referral, using aldomet. Future 
programs should focus on re-training providers and women’s group leaders, and scaling up these 
approaches, as tested in Cross River and Ebonyi. These two interventions, detailed in separate reports, are 




There seem to be inter-regional differences in community and survivor perceptions of roles of religious and 
TBAs in shaping pregnancy care, including ANC attendance and interpretation of danger signs and 
symptoms. In the southern states (Cross River and Ebonyi), women reported the influence of TBAs on their 
health care-seeking behaviors. In the northern state (Kogi), religious leaders also wield influence. As a 
consequence, this study shows mixed or simultaneous use of traditional and health facility-based services. 
In future endeavors, working more closely with both religious leaders and TBAs would make programmatic 
sense.  
Limitations  
One limitation of these data are the unequal sample sizes from ANC observations at baseline and endline, 
but triangulation among different data sources and types render our study findings robust. Provider 
industrial actions (i.e. strikes) and absenteeism resulted in barriers to effective regular mentoring of health 
facilities and consistent ANC visits for pregnant women, and posing challenges to monitoring the women 
enrolled in the study. Besides Cross River, the project did not implement community interventions to raise 
awareness of PE/E and improve ANC, and this may have contributed to variations in women’s knowledge 
of pre-eclampsia and other pregnancy complications in the other two states. Provider re-deployment, 
sometimes to facilities beyond intervention sites, was also a challenge. Newly deployed health workers 
were included in subsequent refresher training, to improve their skills in PE/E detection and management, 
however. Conflicting training schedules with other implementing partners resulted in fewer health care 
providers attending updates as planned, but the project tried to accommodate this through cascading 
training and mentoring visits in conjunction with state MoHs.  
Conclusion  
There is consistent and strong support from policy-makers to scale up task shifting of MgSO4 loading dose 
administration and referral to higher facilities. This favorable policy environment is substantiated by our 
evaluation of PHC workers’ proven capacities to detect, treat, and manage hypertension and PE/E through 
administration of MgSO4 loading doses and referrals. Facility capacities for detecting, treating, and 
managing PE/E improved, though variable and shifting funding streams affect PE/E supply chains and 
procurement procedures. Inconsistent commodity supply negatively affects the sustainability of PE/E 
detection and treatment, as well as the technical quality of ANC, maternity care, and PNC in facilities.  
Recommendations  
• Streamline state procurement and enhance links to central distribution channels to ensure PHC 
supplies of MgSO4 and anti-hypertensive drugs; 
• State plans should incorporate the PHC model including mentoring and supportive supervision for PHC 
providers’ detection and management of HDP, including PE/E; 
• Support providers through mentoring efforts and supportive supervision for HDP detection and 
management, including PE/E, and improved patient and provider interactions and quality of care; and  
• Increase community awareness and engagement, encourage early ANC, and improve health-seeking 
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